Search Results - James Solomon
- Showing 1 - 4 results of 4
-
1
-
2
The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers by Justin W. Marson, Brittany Maner, Tanner Harding, John Meisenheimer, James Solomon, Matt Leavitt, Nicole Levin, Robert P. Dellavalle, Ian Brooks, Darrell S. Rigel
Published 2021Artigo -
3
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib by Anne Lynn S. Chang, James Solomon, John D. Hainsworth, Leonard H. Goldberg, Edward McKenna, Bann‐Mo Day, Diana M. Chen, Glen J. Weiss
Published 2013Artigo -
4
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma by Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro, Luc Dirix, Karl D. Lewis, John D. Hainsworth, James Solomon, Simon Yoo, Sarah T. Arron, Philip Friedlander, Ellen S. Marmur, Charles M. Rudin, Anne Lynn S. Chang, Jennifer A. Low, Howard Mackey, Robert L. Yauch, Richard Graham, Josina C. Reddy, Axel Hauschild
Published 2012Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Oncology
Adverse effect
Basal cell
Basal cell carcinoma
Biochemistry
Cancer
Cancer research
Clinical trial
Dysgeusia
Hedgehog signaling pathway
Pathology
Signal transduction
Vismodegib
Basal (medicine)
Biology
Carcinoma
Chemistry
Coronavirus disease 2019 (COVID-19)
Dermatology
Disease
Family medicine
Gastroenterology
Gemcitabine
Hedgehog
Infectious disease (medical specialty)
Insulin
Law
MEDLINE